Correction: Expression of genes with biomarker potential identified in skin from DSLD-affected horses increases with age.

The research article focuses on the expression of certain genes in the skin of horses affected by Degenerative Suspensory Ligament Desmitis (DSLD), a progressive disease that causes lameness in horses. The expression of these DSLD-associated genes increases with the horse’s age.

Introduction

The research paper was built on understanding the Degenerative Suspensory Ligament Desmitis (DSLD), a disease that affects horses. The disease results in a chronic, painful condition leading to lameness and it has been linked to the presence and expression of certain genes. One such observation is the fact that the expression of these genes related to DSLD increases with the horse’s age.

Methodology

• The researchers conducted their study on horses diagnosed with DSLD. They collected skin samples from these horses and studied them in detail.
• The gene profiling was done using gene sequencing techniques, and the expression levels of the identified genes were measured.
• Various age groups of horses were considered in the study to clearly establish the correlation between the horse’s age and the expression of these DSLD-related genes.

Results and Findings

• The study found that certain genes are indeed expressed more in DSLD-affected horses’ skin, signifying their role in the disease progression.
• Moreover, these genes were found to be expressed at a higher level in older horses. This suggests that the severity of the disease might get worse with age due to the increased gene expression.

Conclusion

The findings from this research article indicate a link between DSLD in horses and the expression of certain biomarker genes. The observation that the expression of these genes increases with age adds greater depth to our understanding of the disease. However, further research is needed to fully understand the complete role of these genes in the development and progression of DSLD. More in-depth genetic studies would help identify potential therapeutic targets for managing this disease in horses.